相关实验视频
Updated: Sep 30, 2026

08:42
Myo-mechanical Analysis of Isolated Skeletal Muscle
Published on: February 22, 2011
概括
迪亚泽帕姆通过防止高剂量的细胞融合,破坏了胚胎的肌肉细胞分化. 较低剂量抑制了髓合成,表明融合不需要肌肉特异性蛋白质积累.
科学领域:
- 肌肉细胞生物学 肌肉细胞生物学
- 发育生物学是发展生物学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌肉细胞分化是一个复杂的过程,涉及肌细胞融合和肌肉特异性蛋白质的合成.
- 了解调节肌体发生的分子机制对于再生医学和理解肌肉疾病至关重要.
研究的目的:
- 在实验室中研究子胚胎髓母细胞分化上泽巴姆的作用.
- 确定泽影响肌细胞融合和肌肉特异性蛋白质合成的特定机制.
主要方法:
- 建立了胚胎髓母细胞的初级培养.
- 用不同度的迪亚泽帕姆治疗肌细胞.
- 评估了细胞融合,肌管形成和肌重链合成.
主要成果:
- 迪亚泽巴姆以剂量依赖的方式阻止了正常肌肉细胞的分化.
- 高度的迪亚泽巴姆可逆地抑制了肌细胞融合到多核肌管.
- 较低的度允许细胞融合,但显著抑制了髓重链合成和积累.
结论:
- 迪亚泽巴姆对肌肉细胞分化产生直接和特定的抑制作用.
- 肌细胞融合不一定与大量肌肉特异性蛋白质的合成和积累相结合,如肌肉素重链.
- 这些发现提供了关于肌肉发育调节的见解,以及某些药物对肌肉发育的潜在影响.
相关概念视频
Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...

